6-24528034-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_001080.3(ALDH5A1):āc.1211C>Gā(p.Ala404Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH5A1 | NM_001080.3 | c.1211C>G | p.Ala404Gly | missense_variant | 8/10 | ENST00000357578.8 | NP_001071.1 | |
ALDH5A1 | NM_170740.1 | c.1250C>G | p.Ala417Gly | missense_variant | 9/11 | NP_733936.1 | ||
ALDH5A1 | NM_001368954.1 | c.1067C>G | p.Ala356Gly | missense_variant | 7/9 | NP_001355883.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000231 AC: 58AN: 251420Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135878
GnomAD4 exome AF: 0.000140 AC: 205AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.000143 AC XY: 104AN XY: 727204
GnomAD4 genome AF: 0.000190 AC: 29AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74456
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25553455) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 27, 2021 | - - |
Intellectual disability Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Strasbourg University Hospital | Dec 01, 2018 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2021 | The c.1211C>G (p.A404G) alteration is located in exon 8 (coding exon 8) of the ALDH5A1 gene. This alteration results from a C to G substitution at nucleotide position 1211, causing the alanine (A) at amino acid position 404 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Succinate-semialdehyde dehydrogenase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at